CRISPR Tx Adds Former McKinsey, Pfizer Execs to Management Team

Xconomy Boston — 

CRISPR Therapeutics has added two executives to its management team. Former McKinsey and Co. partner Samarth Kulkarni is now the company’s chief business officer, and Michael Bruce, most recently a Pfizer executive, is CRISPR’s senior vice president of program portfolio and alliance management. CRISPR was formed in Basel, Switzerland, but recently opened up an office in Cambridge, MA. The startup is one of a group of companies trying to use a gene editing technology called CRISPR-Cas9 for human therapeutics.